Filter
1123
Filtered Results: 1123
Text search:
Strengthening
Pharmaceutical
Systems
Featured
Recommendations
85
New Publications
360
Language
Document type
No document type
631
Studies & Reports
225
Guidelines
122
Strategic & Response Plan
67
Manuals
40
Fact sheets
15
Training Material
13
Situation Updates
6
Brochures
2
Resource Platforms
1
Infographics
1
Countries / Regions
Global
54
Ethiopia
49
Kenya
47
India
44
Sierra Leone
28
Uganda
27
Liberia
27
Nigeria
25
Western and Central Europe
25
South Africa
25
Rwanda
24
Nepal
21
Tanzania
19
Bangladesh
19
Zambia
19
Malawi
17
Namibia
17
Philippines
14
Africa
14
Ukraine
13
Ghana
13
Syria
13
Cambodia
13
South–East Asia Region
13
Eastern Europe
13
Lesotho
12
Latin America and the Carribbean
11
Indonesia
11
Zimbabwe
9
West and Central Africa
8
Botswana
7
Myanmar / Burma
7
Asia
6
Congo, Democratic Republic of
6
East and Southern Africa
6
Eswatini/ Swaziland
6
Thailand
5
Senegal
5
Burkina Faso
5
Guinea
5
Cameroon
4
Albania
4
Haiti
4
Eastern Europe and Central Asia
4
Pakistan
4
Laos
3
Afghanistan
3
Mozambique
3
Jordan
3
Middle East and North Africa
3
Western Pacific Region
3
Lebanon
3
South Sudan
3
North Macedonia
2
Benin
2
China
2
Peru
2
USA
2
Lithuania
2
Germany
2
North America
2
Vietnam
2
Papua New Guinea
2
Sudan
2
Yemen
2
Timor Leste/ East Timor
1
El Salvador
1
Iran
1
Fiji
1
Kyrgyzstan
1
Niger
1
Bulgaria
1
Venezuela
1
Gabon
1
Turkmenistan
1
Japan
1
Maldives
1
Southern Africa
1
Brazil
1
Moldova
1
Sri Lanka
1
Russia
1
Egypt
1
Romania
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
506
Public Health
77
Clinical Guidelines
51
Key Resources
44
Women & Child Health
22
Pharmacy & Technologies
13
Capacity Building
6
Toolboxes
AMR
119
COVID-19
78
Pharmacy
59
TB
58
HIV
52
Mental Health
49
Rapid Response
34
Planetary Health
29
Global Health Education
29
Health Financing Toolbox
26
NTDs
23
Conflict
23
Caregiver
21
NCDs
21
Ebola
16
Specific Hazards
7
Disability
7
Refugee
6
Natural Hazards
6
Polio
6
Social Ethics
3
Health Financing
2
Cholera
1
Zika
1
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
This report assesses the impact of the conflict in Ukraine and its implications for organized crime and security-related issues for neighbouring countries, with a focus on Moldova.
These include:
Organized crime and illicit trafficking (including trafficking in persons, drugs, arms, illicit toba...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic t...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
The aim of the present paper is to review capacity building in public health nutrition (PHN), the need for which has been stressed for many years by a range of academics, national and international organisations. Although great strides have been made worldwide in the science of nutrition, there rema...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
The Global Asthma Report (GAR) 2022, prepared by the Global Asthma Network (GAN), is the fourth such report (others 2011, 2014, 2018). GAN builds upon the work of the International Study of Asthma and Allergies in Childhood (ISAAC) and The International Union Against Tuberculosis and Lung Disease (T...
